echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > ANZ research may help treat sepsis

    ANZ research may help treat sepsis

    • Last Update: 2020-12-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    SYDNEY, Oct. 8 (Xinhua Guo Yang) Australian researchers recently published a paper in the British journal Nature Immunology, said they found a protein-like body played a key role in triggering an inflammatory response to sepsis, a finding that could be used to develop new treatments for sepsis.
    is a disease caused by the immune system's overreaction to infection, which can lead to severe inflammatory reactions in the body, which in turn can lead to tissue death and multi-organ failure.
    researchers at le Drobo University in Australia and others have found that a protein subject called TREML4 is a key regulatory factor that triggers an inflammatory response to sepsis and immune apoptosis. Experiments in mice showed that the overall survival rate of mice with sepsis increased after the protein was removed.
    , an associate professor at the University of Le Drobo, said existing treatments often focus on suppressing inflammatory responses, but at the same time destroy the immune system and weaken the body's ability to fight infection. In contrast, the removal of TREML4 protein subjects is more "moderate", although there will be some inflammation, but the body's immune system is more resistant to infection.
    researchers say they have found receptors in humans that correspond to TREML4 protein receptors, and the next phase will focus on developing therapeutic antibodies against TREML4 protein receptors.
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.